Clinical trial
Atrial Fibrillation Ablation and Autonomic Modulation Via Thoracoscopic Surgery, 10 Year Follow up.
NCT06493591 is registered in ClinicalTrials.gov with Amsterdam UMC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Atrial Fibrillation Ablation and Autonomic Modulation Via Thoracoscopic Surgery, 10 Year Follow up.
- Lead sponsor
- Amsterdam UMC
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- September 1, 2024
- Completion date
- August 1, 2025
- Enrollment
- 200 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.